Your browser doesn't support javascript.
loading
Twelve-Month Outcomes of the AFFINITY Trial of Fluoxetine for Functional Recovery After Acute Stroke: AFFINITY Trial Steering Committee on Behalf of the AFFINITY Trial Collaboration.
Hankey, Graeme J; Hackett, Maree L; Almeida, Osvaldo P; Flicker, Leon; Mead, Gillian E; Dennis, Martin S; Etherton-Beer, Christopher; Ford, Andrew H; Billot, Laurent; Jan, Stephen; Lung, Thomas; Lundström, Erik; Sunnerhagen, Katharina S; Anderson, Craig S; Thang-Nguyen, Huy; Gommans, John; Yi, Qilong.
Affiliation
  • Hankey GJ; Medical School, Faculty of Health and Medical Sciences, The University of Western Australia, Perth, Western Australia, Australia (G.J.H., O.P.A., L.F.).
  • Hackett ML; Department of Neurology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia (G.J.H.).
  • Almeida OP; The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, Australia (M.L.H., S.J., T.L., C.S.A.).
  • Flicker L; The University of Central Lancashire, Preston, England (M.L.H.).
  • Mead GE; Medical School, Faculty of Health and Medical Sciences, The University of Western Australia, Perth, Western Australia, Australia (G.J.H., O.P.A., L.F.).
  • Dennis MS; Medical School, Faculty of Health and Medical Sciences, The University of Western Australia, Perth, Western Australia, Australia (G.J.H., O.P.A., L.F.).
  • Etherton-Beer C; Royal Perth Hospital, Perth, Western Australia, Australia (L.F.).
  • Ford AH; University of Edinburgh, Royal Infirmary, Scotland (G.E.M., M.S.D.).
  • Billot L; University of Edinburgh, Royal Infirmary, Scotland (G.E.M., M.S.D.).
  • Jan S; The University of Western Australia, Perth, Western Australia, Australia (C.E.-B., A.H.F.).
  • Lung T; The University of Western Australia, Perth, Western Australia, Australia (C.E.-B., A.H.F.).
  • Lundström E; Statistics Division, The George Institute for Global Health, Sydney, New South Wales, Australia (L.B.).
  • Sunnerhagen KS; Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia (L.B., T.L., C.S.A.).
  • Anderson CS; The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, Australia (M.L.H., S.J., T.L., C.S.A.).
  • Thang-Nguyen H; The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, Australia (M.L.H., S.J., T.L., C.S.A.).
  • Gommans J; Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia (L.B., T.L., C.S.A.).
  • Yi Q; Department of Neuroscience, Neurology, Uppsala University, Uppsala, Sweden (E.L.).
Stroke ; 52(8): 2502-2509, 2021 08.
Article in En | MEDLINE | ID: mdl-34015940
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Fluoxetine / Selective Serotonin Reuptake Inhibitors / Cognition / Recovery of Function / Stroke Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Stroke Year: 2021 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Fluoxetine / Selective Serotonin Reuptake Inhibitors / Cognition / Recovery of Function / Stroke Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Stroke Year: 2021 Document type: Article Country of publication: Estados Unidos